Literature DB >> 3043717

Quantitative assessment of human proteinases as agents for chemonucleolysis.

P M Dando1, D B Morton, D J Buttle, A J Barrett.   

Abstract

A rabbit model system is described. It allows accurate measurement of the dose-dependent loss of glycosaminoglycan from the nucleus pulposus of lumbar intervertebral discs after injection of a proteinase. At the dose equivalent to that of chymopapain used in human chemonucleolysis, two human serine proteinases, cathepsin G and chymotrypsin, were as effective as chymopapain in removing up to 80% of the glycosaminoglycan from the disc. A cysteine proteinase, cathepsin B released no more than 45% of glycosaminoglycan. X-ray films clearly showed narrowing of the disc space when 30-40% of glycosaminoglycan was removed. The degradation of the nucleus pulposus was seen histologically as loss of toluidine blue metachromasia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3043717     DOI: 10.1097/00007632-198802000-00010

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  3 in total

1.  Evaluation of digestive proteinases from the Antarctic krill Euphasia superba as potential chemonucleolytic agents. In vitro and in vivo studies.

Authors:  J Melrose; A Hall; C Macpherson; C R Bellenger; P Ghosh
Journal:  Arch Orthop Trauma Surg       Date:  1995       Impact factor: 3.067

2.  Chemonucleolysis with Chondroitin Sulfate ABC Endolyase for Treating Lumbar Disc Herniation: Exploration of Prognostic Factors for Good or Poor Clinical Outcomes.

Authors:  Katsuhiko Ishibashi; Muneyoshi Fujita; Yuichi Takano; Hiroki Iwai; Hirohiko Inanami; Hisashi Koga
Journal:  Medicina (Kaunas)       Date:  2020-11-19       Impact factor: 2.430

Review 3.  The Proteolysis of ECM in Intervertebral Disc Degeneration.

Authors:  Huaizhen Liang; Rongjing Luo; Gaocai Li; Weifeng Zhang; Yu Song; Cao Yang
Journal:  Int J Mol Sci       Date:  2022-02-02       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.